Article Information
History
- May 8, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jorunn Stamnaes1,2,*,
- Daniel Stray1,2,
- Maria Stensland2,
- Vikas K. Sarna1,3,
- Tuula A. Nyman2,
- Knut E. A. Lundin1,4 and
- Ludvig M. Sollid1,2,*
- 1K. G. Jebsen Centre for Coeliac Disease Research, University of Oslo, 0424 Oslo, Norway;
- 2Department of Immunology, Oslo University Hospital-Rikshospitalet and University of Oslo, Oslo 0372, Norway;
- 3Department of Gastroenterology, Oslo University Hospital-Ullevål, 0372 Oslo, Norway
- 4Department of Gastroenterology, Oslo University Hospital-Rikshospitalet, 0372 Oslo, Norway
- ↵*Corresponding authors: Jorunn Stamnaes, KG Jebsen Coeliac Disease Research Centre, Department of Immunology, Oslo University Hospital-Rikshospitalet and University of Oslo, 0424 Oslo, Norway. Phone: 0047 98655528, Email: jorunn.stamnas{at}medisin.uio.no, Ludvig M Sollid, KG Jebsen Coeliac Disease Research Centre, Department of Immunology, Oslo University Hospital-Rikshospitalet and University of Oslo, 0424 Oslo, Norway. Phone: 0047 23073811, Email: l.m.sollid{at}medisin.uio.no
Posted May 08, 2020.
Quantitative proteomics of coeliac gut during 14-day gluten challenge: low-level baseline inflammation despite clinical and histological normality predicts subsequent response
